CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK

This approval marks the second international marketing authorization for sugemalimab outside of China, following its recent approval by the European Commission. The approval is based on results from the Phase 3 GEMSTONE-302 clinical trial, which demonstrated that sugemalimab in combination with chemotherapy significantly prolonged progression-free survival (PFS) and overall survival (OS) in treatment-naive patients with… Continue reading CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK

Assan Alüminyum Acquires Solar Power Plant to Boost Sustainability Efforts

ISTANBUL, Oct. 31, 2024 /PRNewswire/ — Assan Alüminyum, one of the world’s leading flat-rolled aluminium producers, has strengthened its sustainability efforts with the acquisition of a solar power plant located in Karaman. The facility, which covers an area of 11.37 hectares, has an installed clean energy generation capacity of 10 MWp, marking a significant step… Continue reading Assan Alüminyum Acquires Solar Power Plant to Boost Sustainability Efforts

Aker Carbon Capture ASA: Third quarter 2024 results

FORNEBU, Norway, Oct. 31, 2024 /PRNewswire/ — Aker Carbon Capture ASA (“ACC ASA”) closed the third quarter 2024 with NOK 4.5 billion in cash and a solid equity position at NOK 5.5 billion. “Through our 20% ownership stake in the joint venture with SLB, which holds the remaining 80%, we will continue to scale and… Continue reading Aker Carbon Capture ASA: Third quarter 2024 results

Aker Carbon Capture ASA: Third quarter 2024 results

FORNEBU, Norway, Oct. 31, 2024 /PRNewswire/ — Aker Carbon Capture ASA (“ACC ASA”) closed the third quarter 2024 with NOK 4.5 billion in cash and a solid equity position at NOK 5.5 billion. “Through our 20% ownership stake in the joint venture with SLB, which holds the remaining 80%, we will continue to scale and… Continue reading Aker Carbon Capture ASA: Third quarter 2024 results

ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs)

Celltrion USA has expanded access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous (SC) infliximab, to a significant share of the U.S. market The availability of ZYMFENTRA will support greater patient access and choice while helping to drive greater affordability to patients and health care systems JERSEY CITY, N.J., Oct. 31, 2024 /PRNewswire/ — Celltrion USA announced today that,… Continue reading ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs)

Assan Alüminyum acquiert une centrale solaire pour renforcer ses efforts en matière de développement durable

ISTANBUL, 31 octobre 2024 /PRNewswire/ — Assan Alüminyum, l’un des principaux producteurs mondiaux d’aluminium laminé à plat, a renforcé ses efforts en matière de développement durable avec l’acquisition d’une centrale solaire située à Karaman. L’installation, qui couvre une superficie de 11,37 hectares, a une capacité installée de production d’énergie propre de 10 MWp, ce qui… Continue reading Assan Alüminyum acquiert une centrale solaire pour renforcer ses efforts en matière de développement durable

Nissan primes Renault Twingo twin for Europe

Nissan is in the early stages of developing an electric city car for Europe, twinned with the upcoming Renault Twingo EV. The Japanese firm has begun talks with Alliance partner Renault’s Ampere EV division about the development of an ‘A-segment’ EV based on the Ampr Small platform that underpins the forthcoming Twingo (as well as the larger… Continue reading Nissan primes Renault Twingo twin for Europe

M.D.C. HOLDINGS ANNOUNCES DEPARTURE OF FOUNDER AND EXECUTIVE CHAIRMAN LARRY A. MIZEL AND PRESIDENT AND CHIEF EXECUTIVE OFFICER DAVID D. MANDARICH AT THE END OF 2024

DENVER, Oct. 30, 2024 /PRNewswire/ — M.D.C. Holdings, Inc. (“MDC”), one of the leading homebuilders in the U.S. delivering high-quality homes over the past 50 years and a subsidiary of Sekisui House, Ltd. (“Sekisui House”), a top-tier house manufacturer in Japan having delivered over 2.66 million homes worldwide since its establishment, announced today that Larry… Continue reading M.D.C. HOLDINGS ANNOUNCES DEPARTURE OF FOUNDER AND EXECUTIVE CHAIRMAN LARRY A. MIZEL AND PRESIDENT AND CHIEF EXECUTIVE OFFICER DAVID D. MANDARICH AT THE END OF 2024

Laird Superfood and Smirk’s LTD, Two Colorado Companies, Renew Strategic Partnership

SISTERS, Ore., Oct. 30, 2024 /PRNewswire/ — Laird Superfood, a leading provider of premium, functional plant-based products, and Smirk’s LTD, a renowned supplier of organic and natural ingredients, are proud to announce that they have successfully reconciled recent challenges and have renewed their strategic partnership. Both companies are excited to continue working together to bring… Continue reading Laird Superfood and Smirk’s LTD, Two Colorado Companies, Renew Strategic Partnership